Overall rank by patents
#22,119
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Adienne Pharma &biotech Sa
USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ).
12
Total patents granted
9
CPC technology areas
13.3
Avg claims per patent
-29%
5-year filing velocity
The verdict
Adienne holds 12 US patents across 9 technology areas, rank #22,119 of 50,000 tracked assignees.
- #22,119
- of 50,000 US assignees by volume
- Top 64%
- by Innovation Score (30.8/100)
- 13.3
- avg claims per patent
- -29%
- filing velocity, last 5 yrs
Portfolio overview
Adienne Pharma &biotech Sa has been granted 12 US utility patents between 2018 and 2025, placing Adienne Pharma &biotech Sa at rank #22,119 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.3 claims per patent with primary concentration in A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ). As a Foreign Corporation, Adienne Pharma &biotech Sa is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 30.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 7 in the 2015–2019 window, a -29% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Adienne Pharma &biotech Sa's 13.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Adienne Pharma &biotech Sa against peers pursuing similar technology classes.
How does Adienne compare?
Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Adienne Pharma &B… ◀ 12
ADIENNE PHARMA &BIOTECH SA
12 patents
What this shows Adienne holds 12 patents, placing it at rank #22,119 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Adienne's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
31 Top 64% higher than 36% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
USPTO utility patent grants by year · 2018–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 16.7% |
| 2019 | 5 | 41.7% |
| 2021 | 1 | 8.3% |
| 2022 | 1 | 8.3% |
| 2023 | 1 | 8.3% |
| 2024 | 1 | 8.3% |
| 2025 | 1 | 8.3% |
Which technologies does Adienne Pharma &biotech Sa patent most?
Top 9 of 9 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Adienne Pharma &biotech Sa hold?
Adienne Pharma &biotech Sa holds 12 US granted patents filed between 2018 and 2025, spanning 9 technology areas.
What is Adienne Pharma &biotech Sa's Innovation Score?
Adienne Pharma &biotech Sa has an Innovation Score of 30.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Adienne Pharma &biotech Sa focus on?
Adienne Pharma &biotech Sa's top technology area is A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE) with 10 patents. The company has filed patents in 9 CPC subclasses total.
Is Adienne Pharma &biotech Sa's patent filing rate increasing or decreasing?
Adienne Pharma &biotech Sa's recent filing velocity is -29% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Adienne Pharma &biotech Sa's patents?
Adienne Pharma &biotech Sa's patents average 13.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the Adienne Pharma &biotech Sa patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Guides to patent portfolio analysis
How to use this portfolio
Adienne's 12 grants land it in the top 64% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Adienne ranks #22,119 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61J - see who else leads that technology area. A61J leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Explore the patent dataset
A61J technology
Adienne Pharma &biotech Sa's primary CPC class, all holders and yearly trends
Top 50 patent holders
See where Adienne Pharma &biotech Sa ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Data sources used on this page
- USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
- Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
- USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.